CNS TUMOR
Clinical trials for CNS TUMOR explained in plain language.
Never miss a new study
Get alerted when new CNS TUMOR trials appear
Sign up with your email to follow new studies for CNS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with Tough-to-Treat cancers
Disease control CompletedThis study tested a drug called avapritinib in children and teenagers (ages 2-18) with advanced solid tumors, including brain tumors, that had come back or stopped responding to standard treatments. The tumors needed to have specific genetic changes (in KIT or PDGFRA genes). The …
Matched conditions: CNS TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated Apr 04, 2026 04:36 UTC
-
Trial tests Gadolinium-Free MRI dye to spot brain tumors and MS lesions
Diagnosis CompletedThis study tested a new type of MRI contrast dye called RVP-001, which is based on manganese instead of the commonly used gadolinium. It involved 18 adults with known brain or spinal cord lesions from conditions like tumors or multiple sclerosis. The main goal was to see if RVP-0…
Matched conditions: CNS TUMOR
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Apr 04, 2026 04:35 UTC
-
Doctors track brain tumor patients to see how treatment works in real life
Knowledge-focused CompletedThis study observed 272 adult brain tumor patients who received Gliadel wafers as part of their normal medical care. Researchers tracked patients for up to three years to collect real-world information on how long patients lived, whether their cancer returned, and what side effec…
Matched conditions: CNS TUMOR
Sponsor: Arbor Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 06, 2026 15:37 UTC